Skip to main content
. 2022 Nov 7;22:403. doi: 10.1186/s12890-022-02183-9

Table 2.

Comparison of the indicators between DM patients with severe CAP and non-severe CAP in the training set

Characteristic Non-severe CAP
(n = 639)
Severe CAP
(n = 79)
p
Demographic data
Sex [n(%)] Female 284 (44.4) 27 (34.2) 0.106
Male 355 (55.6) 52 (65.8)
Age [n(%)] < 65 229 (35.8) 31 (39.2) 0.639
≥ 65 410 (64.2) 48 (60.8)
Current smoker [n(%)] 0 478 (74.9) 58 (73.4) 0.878
1 160 (25.1) 21 (26.6)
Alcohol abuse [n(%)] 0 593 (92.9) 74 (93.7) 0.997
1 45 ( 7.1) 5 ( 6.3)
Temperature < 36.3 °C or ≥ 37.2 °C [n(%)] 0 108 (16.9) 7 ( 8.9) 0.094
1 531 (83.1) 72 (91.1)
Comorbid condition
Hypertension [n(%)] 0 296 (46.3) 27 (34.2) 0.054
1 343 (53.7) 52 (65.8)
Chronic respiratory disease [n(%)] 0 542 (84.8) 58 (73.4) 0.016
1 97 (15.2) 21 (26.6)
Cardiac dysfunction [n(%)] 0 534 (83.6) 54 (68.4) 0.002
1 105 (16.4) 25 (31.6)
Cerebrovascular disease [n(%)] 0 549 (85.9) 64 (81.0) 0.320
1 90 (14.1) 15 (19.0)
Chronic kidney dysfunction [n(%)] 0 603 (94.4) 62 (78.5) < 0.001
1 36 ( 5.6) 17 (21.5)
Rheumatic disorders [n(%)] 0 627 (98.1) 76 (96.2) 0.479
1 12 ( 1.9) 3 ( 3.8)
Malignant tumor [n(%)] 0 606 (94.8) 64 (81.0) < 0.001
1 33 ( 5.2) 15 (19.0)
Long-term glucocorticoid medication [n(%)] 0 625 (97.8) 73 (92.4) 0.017
1 14 ( 2.2) 6 ( 7.6)
Laboratory data
Neu < 2 or ≥ 7*10^9/L [n(%)] 0 369 (57.7) 17 (21.5) < 0.001
1 270 (42.3) 62 (78.5)
L < 0.8 or ≥ 4*10^9/L [n(%)] 0 467 (73.1) 38 (48.1) < 0.001
1 172 (26.9) 41 (51.9)
PLT < 85 or ≥ 300*10^9/L [n(%)] 0 491 (76.8) 58 (73.4) 0.592
1 148 (23.2) 21 (26.6)
ALB < 35 g/L [n(%)] 0 298 (46.6) 5 ( 6.3) < 0.001
1 341 (53.4) 74 (93.7)
HbA1c > 42.07mmol/mol [n(%)] 0 106 (16.6) 1 ( 1.3) 0.001
1 533 (83.4) 78 (98.7)

Neu, Neutrophil; L, Lymphocyte; PLT, Platelet; ALB, Albumin; HbA1c, glycosylated hemoglobin